Indication: Transient Myeloproliferative Disorder (TMD)
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome (DS)
Sub-indication: Transient Myeloproliferative Disorder (TMD)
Study Type: Specimen Study
Principal Investigator: Ashok Raj, M.D.Norton Children's Cancer Institute, affiliated with the UofL School of Medicine
Sponsor: Sponsor: Children's Oncology Group (COG)
Learn more at ClinicalTrials.gov
Email for more information: NCRI-Cancer@NortonHealthcare.org
